|Articles|February 19, 2016
Therapeutic Innovation & Regulatory Science: An Increasingly Global Approach
Author(s)DIA
Advertisement
A series of contributions emphasizing the increasingly global nature of medical product development and regulation is highlighted in this issue with contributions from around the world. Additional articles on central monitoring, clinical trial outcomes, and data quality are also included.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Elicio Therapeutics’ Shares Drop Following Announcement of Phase II Trial Results
2
Pharma Roundup: FDA Approves Truqap Plus Abiraterone and Prednisone, FDA Approves Keytruda and Keytruda Qlex Each in Combination with Welireg
3
Partnering in Non-Opioids: Q&A with Dr. Edward Littler and Dave Watson
4
Pharmaceutical Executive Daily: FDA Approves Two Indications of Keytruda in Combination with Welireg
5